Discover
ACIU
AC Immune S.A.
2.61
1 x 2.61
5 x 2.62
bid
ask
+
0.33
14.47%
12:30 PM
timesize
| Ytd | -16.88% | |
| 1y | 26.09% |
2.35
day range
2.70
2.03
52 week range
4.00
| Open | 2.50 | Prev Close | 2.28 | Low | 2.35 | High | 2.70 | Mkt Cap | 266.35M |
| Vol | 769.94K | Avg Vol | 251.87K | EPS | -0.54 | P/E | -4.85 | Forward P/E | -10.72 |
| Beta | 1.59 | Short Ratio | 8.14 | Inst. Own | 28.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 2.36 | 200-d Avg | 2.89 | 1yr Est | 10.01 |
| Income Statement | |||
| Total Revenue | 15.11M | ||
| Revenues (USD) | 18.66M | ||
| Gross Profit | 15.11M | ||
| Operating Expenses | 13.92M | ||
| Research and Development Expense | 10.48M | ||
| Selling, General and Administrative Expense | 3.54M | ||
| Operating Income | 1.19M | ||
| Interest Expense | 61.00K | ||
| Net Income | 1.87M | ||
| Net Income Common Stock | 1.87M | ||
| Net Income Common Stock (USD) | 2.31M | ||
| Consolidated Income | 1.87M | ||
| Earnings per Basic Share | 0.02 | ||
| Earnings per Basic Share (USD) | 0.03 | ||
| Earnings per Diluted Share | 0.02 | ||
| Earning Before Interest & Taxes (EBIT) | 1.94M | ||
| Earning Before Interest & Taxes (USD) | 2.39M | ||
| Weighted Average Shares | 101.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 27.76M | ||
| Cash and Equivalents (USD) | 34.27M | ||
| Investments | 48.19M | ||
| Investments Current | 47.60M | ||
| Investments Non-Current | 585.00K | ||
| Trade and Non-Trade Receivables | 13.44M | ||
| Current Assets | 93.40M | ||
| Property, Plant & Equipment Net | 6.00M | ||
| Total Assets | 150.40M | ||
| Debt Current | 835.00K | ||
| Total Debt | 4.10M | ||
| Current Liabilities | 100.24M | ||
| Debt Non-Current | 3.27M | ||
| Total Liabilities | 115.23M | ||
| Accumulated Retained Earnings (Deficit) | -450.44M | ||
| Accumulated Other Comprehensive Income | 9.00K | ||
| Shareholders Equity | 35.17M | ||
| Shareholders Equity (USD) | 43.42M | ||
| Assets Non-Current | 57.00M | ||
| Total Debt (USD) | 5.06M | ||
| Deferred Revenue | 93.41M | ||
| Goodwill and Intangible Assets | 50.42M | ||
| Liabilities Non-Current | 14.99M | ||
| Trade and Non-Trade Payables | 1.51M | ||